Beijing attorney wants Pfizer probed for bribery; FDA plans Aurobindo inspections;

 @FiercePharma: Maybe K-V Pharma should have listened to Facebook as the Makena pricing furor grew: More | Follow @FiercePharma

> A Beijing lawyer is lobbying the Chinese government to investigate Pfizer ($PFE) for bribery after the company settled a Foreign Corrupt Practices Act investigation in the U.S. Report

> FDA plans to inspect two Aurobindo Pharma facilties in India this fall, one of which has been under an import alert since February 2011. Report

> Santarus sued Dr. Reddy's Laboratories for patent infringement after the Indian generics maker asked FDA to approve copycat versions of the heartburn drug Zegerid. Report

> Actavis notified Medicis Pharmaceuticals that it had asked FDA to approve a knockoff version of the Medicis skin drug Zyclara. Report

> Johnson & Johnson ($JNJ) says it will pull a series of potentially harmful chemicals from its consumer products, including formaldehyde, after widespread attention to their risks. Report

> Hikma Pharmaceuticals posted a 13% increase in first-half adjusted profits on injectable drug sales that almost doubled. Report

 @FierceMedDev: Is Boston Sci still reeling from its $28B purchase of Guidant? More | Follow @FierceMedDev

 @MarkHFierce: Mission accomplished: Sunshine Heart closes public offering of common stock and pulls in $18 million. Item | Follow @MarkHFierce

 @DamianFierce: Regulus has signed on with Biogen Idec to develop microRNA diagnostics for MS. News | Follow @DamianFierce

> Dartmouth developing device-controlling wristwatch. Story

> FDA sticks Class I tag on Covidien recall. News

Biotech News

 @FierceBiotech: IMS bags planning tech for clinical trials with TTC buyout. News | Follow @FierceBiotech

 @JohnCFierce: Idenix shares eviscerated as clinical hold raises tox fears. Article | Follow @JohnCFierce

 @RyanMFierce: I'm planning a trip to visit my biotech neighbors to the north in Montreal. Looking forward to putting faces to names and so forth. | Follow @RyanMFierce

> Novartis eye drug prevails in PhIII trials ahead of FDA action. News

> Upbeat PhIII results bolster Medivation's big plans for enzalutamide. Story

> Promising colitis data build blockbuster case for Pfizer's tofacitinib. Story

Vaccines News

> Antigen Discovery receives $2.5M grant for malaria vax. Item

> Heart disease vaccine steps closer. Report

> Feds cut Ebola vax funding. More

> FDA approves 6 flu vaccines. Story

Pharma Manufacturing News

> It is overfilled pain drug in latest Hospira recall. News

> Morphotek turns to manufacturing with new plant. Story

> West-Ward plant problems undermine Hikma earnings. Article

And Finally... Scientists have identified the gut bacteria that seem to be linked to obesity and metabolic syndrome. Report